tiprankstipranks
SpyGlass Pharma (SGP)
NASDAQ:SGP
US Market
SGP
SpyGlass Pharma
RESEARCH TOOLSreports
Want to see SGP full AI Analyst Report?

SpyGlass Pharma (SGP) Income Statement

14 Followers

SpyGlass Pharma Income Statement

Last quarter (Q1 2026), SpyGlass Pharma's total revenue was $0.00, a decrease of ― from previous quarter. In Q1, SpyGlass Pharma's net income was $-13.82M. See SpyGlass Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25
Total Revenue
$ 0.00
Gross Profit
$ -612.00K
Operating Expenses
$ 40.84M
Depreciation and Amortization
$ 612.00K
EBITDA
$ -40.84M
Operating Income
$ -41.45M
Other Income/Expenses
$ 1.58M
Pretax Income
$ -39.87M
Net Income
$ -39.87M
Per Share Metrics
Basic EPS
$ -1.19
Diluted EPS
$ -1.19
Weighted Average Shares Outstanding
 33.43M
Weighted Average Shares Outstanding (Diluted)
 33.43M
Currency in USD

SpyGlass Pharma Earnings and Revenue History